PRINCETON, N.J., Dec. 7 /PRNewswire/ -- PharmaNet Development Group, Inc., a leading provider of clinical development services to pharmaceutical, biotechnology, generic drug and medical device companies, announced today that Stephen Kasay has joined the Company as Chief Information Officer.
In his role, Steve will have global responsibility for the Company's corporate information technology function including strategy development and execution and optimization of the Company's technology infrastructure, software and data assets.
"We are delighted to have Steve Kasay join PharmaNet Development Group," commented Jeffrey P. McMullen, president and chief executive officer. "With extensive experience in the pharmaceutical and CRO industry, Steve has the proven executive leadership and expertise needed to support clinical development and laboratory services and our data centers in North America, Europe and Asia."
Mr. Kasay has over twenty years of experience providing direction to information technology (IT) departments in global pharmaceutical companies and clinical research organizations. His accomplishments include the strategic assessment and consolidation of data, the successful implementation of software and infrastructure assets to enhance productivity, the establishment of global IT governance processes, and the development of relationships and communication practices with business partners to continually improve efficiencies and client service.
About PharmaNet Development Group, Inc.
PharmaNet Development Group, Inc., a global drug development services company, provides a comprehensive range of services to the pharmaceutical, biotechnology, generic drug and medical device industries. The Company offers early and late stage consulting, Phase I clinical studies and bioanalytical analyses, and Phase II, III and IV clinical development programs. With approximately 2,3
|SOURCE PharmaNet Development Group, Inc.|
Copyright©2009 PR Newswire.
All rights reserved